ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AEMD Amundi Luxembourg SA

47.7894
0.6604 (1.40%)
19:00:18 - Realtime Data
Name Symbol Market Type
Amundi Luxembourg SA TG:AEMD Tradegate Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.6604 1.40% 47.7894 47.5369 47.7801 47.7894 47.0912 47.4045 1,112 19:00:18

Aethlon Medical, Inc. to Present at the 2009 RedChip New York Equities Conference

29/09/2009 12:30pm

PR Newswire (US)


Amundi Luxembourg (TG:AEMD)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Amundi Luxembourg Charts.
SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), announced today that Jim Joyce, Chairman and Chief Executive Officer of Aethlon Medical, Inc., is scheduled to present at the 2009 RedChip New York Equities Conference being held in New York City on September 30th and October 1st, 2009. The Company's presentation is scheduled for 3:20 pm Eastern time on Wednesday, September 30, 2009 at the NASDAQ MarketSite (4 Times Square, at 43rd and Broadway). (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b) Company presentations will be webcast live and archived for 90 days at http://www.redchip.com/. For additional information or to schedule a one-on-one meeting with Aethlon Medical, Inc. at this event, please contact Jon Cunningham at 407-644-4256, Ext. 107, or email . About Aethlon Medical, Inc. Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at http://www.aethlonmedical.com/. About RedChip Companies, Inc. RedChip Companies is an international, small-cap research and financial public relations firm headquartered in Orlando, Florida; with affiliate offices in Qingdao, China; Paris, and San Diego. Since 1993, RedChip has been a source for small-cap research and investor awareness services for emerging growth companies, delivering concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/productsandservices.asp. Contact: Jim Joyce Chairman, CEO 858.459.7800 x301 Jim Frakes Senior VP Finance 858.459.7800 x300 RedChip Companies, Inc. Jon Cunningham 1-800-733-2447, Ext. 107 http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b http://photoarchive.ap.org/ DATASOURCE: Aethlon Medical, Inc. CONTACT: Jim Joyce, Chairman, CEO, +1-858-459-7800, ext. 301, , or Jim Frakes, Senior VP Finance, +1-858-459-7800, ext. 300, , both of Aethlon Medical, Inc.; or Jon Cunningham of RedChip Companies, Inc., 1-800-733-2447, ext. 107, Web Site: http://www.aethlonmedical.com/ http://www.redchip.com/

Copyright

1 Year Amundi Luxembourg Chart

1 Year Amundi Luxembourg Chart

1 Month Amundi Luxembourg Chart

1 Month Amundi Luxembourg Chart

Your Recent History

Delayed Upgrade Clock